vimarsana.com

Latest Breaking News On - Analyst recommendations for petco health - Page 9 : vimarsana.com

Petco Health and Wellness (NASDAQ:WOOF) Earns Hold Rating from Analysts at StockNews com

StockNews.com began coverage on shares of Petco Health and Wellness (NASDAQ:WOOF – Get Rating) in a report issued on Thursday. The brokerage issued a hold rating on the stock. A number of other research firms also recently issued reports on WOOF. Royal Bank of Canada decreased their price objective on Petco Health and Wellness from […]

Petco Health and Wellness (NASDAQ:WOOF) Price Target Cut to $15 00

Petco Health and Wellness (NASDAQ:WOOF – Get Rating) had its price target dropped by analysts at Needham & Company LLC from $20.00 to $15.00 in a report issued on Friday, The Fly reports. Needham & Company LLC’s price target indicates a potential upside of 60.60% from the stock’s current price. A number of other equities […]

Petco Health and Wellness Company, Inc (NASDAQ:WOOF) Given Consensus Recommendation of Moderate Buy by Brokerages

Petco Health and Wellness Company, Inc. (NASDAQ:WOOF – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month […]

Bank of America Cuts Petco Health and Wellness (NASDAQ:WOOF) Price Target to $14 50

Petco Health and Wellness (NASDAQ:WOOF – Get Rating) had its target price decreased by Bank of America from $18.00 to $14.50 in a research note issued to investors on Wednesday, The Fly reports. Bank of America currently has a buy rating on the stock. WOOF has been the topic of several other research reports. Robert […]

Petco Health and Wellness (NASDAQ:WOOF) Price Target Cut to $8 50

Petco Health and Wellness (NASDAQ:WOOF – Get Rating) had its target price cut by equities research analysts at Citigroup from $11.00 to $8.50 in a report issued on Tuesday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Citigroup’s price objective suggests a potential downside of 5.03% from the stock’s current price. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.